Dra Chemicals Research And Development Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 04-01-2025
- Paid Up Capital ₹ 0.20 M
as on 04-01-2025
- Company Age 46 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 30.00 K
as on 04-01-2025
- Revenue -100.00%
(FY 2022)
- Profit -980.47%
(FY 2022)
- Ebitda -2.53%
(FY 2022)
- Net Worth -26.13%
(FY 2022)
- Total Assets 9.60%
(FY 2022)
About Dra Chemicals Research And Development
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹30,000.00.
Anupam Bansal, Vishnumoorthy Rao, and Pappinisseri Mohanan serve as directors at the Company.
- CIN/LLPIN
U24100MH1978PTC020712
- Company No.
020712
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Oct 1978
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dra Chemicals Research And Development?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anupam Bansal  | Director | 25-Sep-2012 | Current |
Vishnumoorthy Rao  | Director | 11-Feb-2020 | Current |
| Pappinisseri Mohanan | Director | 12-Dec-2019 | Current |
Financial Performance of Dra Chemicals Research And Development.
Dra Chemicals Research And Development Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 100% decrease. The company also saw a substantial fall in profitability, with a 980.47% decrease in profit. The company's net worth observed a substantial decline by a decrease of 26.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dra Chemicals Research And Development?
In 2022, Dra Chemicals Research And Development had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
₹0.03 M
₹0
Charges Breakdown by Lending Institutions
- Dombivli Nagrik Sahakari Bank Ltd. : 0.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Jan 1980 | Dombivli Nagrik Sahakari Bank Ltd. | ₹0.03 M | Open |
How Many Employees Work at Dra Chemicals Research And Development?
Dra Chemicals Research And Development has a workforce of 1 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dra Chemicals Research And Development, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dra Chemicals Research And Development's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
